Cargando…

Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer

PURPOSE: Tumor-free surgical margin is crucial but challenging in breast-conserving surgery (BCS). Fluorescence imaging is a promising strategy for surgical navigation that can reliably assist the surgeon with visualization Of the tumor in real-time. Notably, finding an optimized fluorescent probe h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Rui-Qin, Chen, Min, Zhang, Qiang, Gao, Yi-Yang, Lou, Kang-Liang, Lin, Tong-Tong, Huang, Wen-He, Zeng, Yun-Zhu, Zhang, Yong-Qu, Dang, Yong-Ying, Ren, Lei, Zhang, Guo-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957402/
https://www.ncbi.nlm.nih.gov/pubmed/35345784
http://dx.doi.org/10.2147/IJN.S343479
_version_ 1784676755641991168
author Yang, Rui-Qin
Chen, Min
Zhang, Qiang
Gao, Yi-Yang
Lou, Kang-Liang
Lin, Tong-Tong
Huang, Wen-He
Zeng, Yun-Zhu
Zhang, Yong-Qu
Dang, Yong-Ying
Ren, Lei
Zhang, Guo-Jun
author_facet Yang, Rui-Qin
Chen, Min
Zhang, Qiang
Gao, Yi-Yang
Lou, Kang-Liang
Lin, Tong-Tong
Huang, Wen-He
Zeng, Yun-Zhu
Zhang, Yong-Qu
Dang, Yong-Ying
Ren, Lei
Zhang, Guo-Jun
author_sort Yang, Rui-Qin
collection PubMed
description PURPOSE: Tumor-free surgical margin is crucial but challenging in breast-conserving surgery (BCS). Fluorescence imaging is a promising strategy for surgical navigation that can reliably assist the surgeon with visualization Of the tumor in real-time. Notably, finding an optimized fluorescent probe has been a challenging research topic. Herein, we developed a novel near-infrared (NIR) fluorescent probe based on tailored Hepatitis B Core virus-like protein (HBc VLP) and presented the preclinical imaging-guided surgery. METHODS: The RGD-HBc(160) VLP was synthesized by genetic engineering followed encapsulation of ICG via disassembly-reassembly. The applicability of the probe was tested for cell and tissue binding capacities through cell-based plate assays, xenograft mice model, and MMTV-PyVT mammary tumor transgenic mice. Subsequently, the efficacy of RGD-HBc(160)/ICG-guided surgery was evaluated in an infiltrative tumor-bearing mouse model. The protein-induced body’s immune response was further assessed. RESULTS: The prepared RGD-HBc(160)/ICG showed outstanding integrin α(v)β(3) targeting ability in vitro and in vivo. After intravenous administration of probe, the fluorescence guidance facilitated more complete tumor resection and improved overall survival Of the infiltrative tumor-bearing mice. The probe also showed the excellent capability to differentiate between benign and malignant breast tissues in the mammary tumor transgenic mice. Interestingly, the ingenious tailoring of HBc VLP could not only endow its tumor-targeting ability towards integrin α(v)β(3) but also significantly reduce the humoral and cellular immune response. CONCLUSION: The RGD-HBc(160)/ICG holds promise as an effective tool to delineate tumor margin. These results have translational potential to achieve margin-negative resection and improve the stratification of patients for a potentially curative.
format Online
Article
Text
id pubmed-8957402
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89574022022-03-27 Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer Yang, Rui-Qin Chen, Min Zhang, Qiang Gao, Yi-Yang Lou, Kang-Liang Lin, Tong-Tong Huang, Wen-He Zeng, Yun-Zhu Zhang, Yong-Qu Dang, Yong-Ying Ren, Lei Zhang, Guo-Jun Int J Nanomedicine Original Research PURPOSE: Tumor-free surgical margin is crucial but challenging in breast-conserving surgery (BCS). Fluorescence imaging is a promising strategy for surgical navigation that can reliably assist the surgeon with visualization Of the tumor in real-time. Notably, finding an optimized fluorescent probe has been a challenging research topic. Herein, we developed a novel near-infrared (NIR) fluorescent probe based on tailored Hepatitis B Core virus-like protein (HBc VLP) and presented the preclinical imaging-guided surgery. METHODS: The RGD-HBc(160) VLP was synthesized by genetic engineering followed encapsulation of ICG via disassembly-reassembly. The applicability of the probe was tested for cell and tissue binding capacities through cell-based plate assays, xenograft mice model, and MMTV-PyVT mammary tumor transgenic mice. Subsequently, the efficacy of RGD-HBc(160)/ICG-guided surgery was evaluated in an infiltrative tumor-bearing mouse model. The protein-induced body’s immune response was further assessed. RESULTS: The prepared RGD-HBc(160)/ICG showed outstanding integrin α(v)β(3) targeting ability in vitro and in vivo. After intravenous administration of probe, the fluorescence guidance facilitated more complete tumor resection and improved overall survival Of the infiltrative tumor-bearing mice. The probe also showed the excellent capability to differentiate between benign and malignant breast tissues in the mammary tumor transgenic mice. Interestingly, the ingenious tailoring of HBc VLP could not only endow its tumor-targeting ability towards integrin α(v)β(3) but also significantly reduce the humoral and cellular immune response. CONCLUSION: The RGD-HBc(160)/ICG holds promise as an effective tool to delineate tumor margin. These results have translational potential to achieve margin-negative resection and improve the stratification of patients for a potentially curative. Dove 2022-03-22 /pmc/articles/PMC8957402/ /pubmed/35345784 http://dx.doi.org/10.2147/IJN.S343479 Text en © 2022 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yang, Rui-Qin
Chen, Min
Zhang, Qiang
Gao, Yi-Yang
Lou, Kang-Liang
Lin, Tong-Tong
Huang, Wen-He
Zeng, Yun-Zhu
Zhang, Yong-Qu
Dang, Yong-Ying
Ren, Lei
Zhang, Guo-Jun
Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
title Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
title_full Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
title_fullStr Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
title_full_unstemmed Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
title_short Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
title_sort development and preclinical evaluation of a near-infrared fluorescence probe based on tailored hepatitis b core particles for imaging-guided surgery in breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957402/
https://www.ncbi.nlm.nih.gov/pubmed/35345784
http://dx.doi.org/10.2147/IJN.S343479
work_keys_str_mv AT yangruiqin developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT chenmin developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT zhangqiang developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT gaoyiyang developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT loukangliang developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT lintongtong developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT huangwenhe developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT zengyunzhu developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT zhangyongqu developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT dangyongying developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT renlei developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer
AT zhangguojun developmentandpreclinicalevaluationofanearinfraredfluorescenceprobebasedontailoredhepatitisbcoreparticlesforimagingguidedsurgeryinbreastcancer